Isocitrate dehydrogenase wild-type glioblastoma (GBM) is the most common and aggressive primary brain tumour in adults, comprising 49% of brain malignancy [1] with a dismal median survival rate of 14 months from diagnosis [2]. This evidence concerns the gene SGCG and glioblastoma.